Abstract:Nav1.4 (SCN4A) p.R675Q is the most common mutation in Chinese patients with skeletal muscle sodium channelopathies. Two patients with R675Q mutation from different neuromuscular diagnosis centers complained of fixed myopathy and recurrent periodic paralysis. Muscle biopsy on biceps were performed for both patients. Clinical features as well as muscle MRI in bilateral lower limbs were retrospectively reviewed. To further explore the underlying mechanism of the central core-like pathology, we performed the immunofluorescence staining (IF) and western blot of Ryanodine receptor-1 (RYR1) and calcium channel voltage-dependent L-type alpha 1S unit (Cav1.1) using muscle specimens. Patient 1 was a 21-year-old male presenting periodic paralysis for over 7 years. Muscle weakness mainly involved bilateral lower limbs and the serum potassium level remained normal. The grandpa reported recurrent paralysis at the early age but other family members did not complain of any neuromuscular abnormalities. Patient 2 was a 28-year-old male with periodic paralysis for 14 years. He had 1-3 episodes per year and the serum potassium was at normal range. The father and a brother in the family tree shared similar clinical presentations. Muscle MRI of bilateral limbs revealed medium gastrocnemius and soleus was selectively involved. Histochemical staining of muscle specimens revealed central core or multi-mini core-like structures in most fibers for Patient 1 and 2 (P1, P2). A patient with periodic paralysis due to p.R675Q mutation but no fixed myopathy was also included in the study (P3). IF staining revealed misdistribution of RYR1 and Cav1.1 protein in comparison to normal control and P3. But still RYR1 and Cav1.1 merged well together. Western blot demonstrated secondary reduction of RYR1 in patients 1 and 3. Misdistribution and secondary reduction of RYR1 may be the underlying mechanism of patients with Nav1.4 R675Q mutation.

SCN4A p.R675Q Mutation Leading to Normokalemic Periodic Paralysis: A Family Report and Literature Review.

Enhanced Slow Inactivation of the Human Skeletal Muscle Sodium Channel Causing Normokalemic Periodic Paralysis

Familial Normokalemic Periodic Paralysis Associated with Mutation in the SCN4A P.m1592v

Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis

Normokalemic and Hypokalemic Periodic Paralysis Coexist in a Family with a Novel R1129Q Mutation in the SCN4A Gene

The clinical,pathological,and genetic features of a family with both hypokalemic and normokalemic periodic paraly-sis

N1366S Mutation of Human Skeletal Muscle Sodium Channel Causes Paramyotonia Congenita

The R900S Mutation in CACNA1S Associated with Hypokalemic Periodic Paralysis

A Novel SCN9A Gene Variant Identified in a Chinese Girl with Paroxysmal Extreme Pain Disorder (PEPD): a Rare Case Report.

[Mutation of Thr704Met in SCN 4A Causes Normokpp in a Chinese Family].

Both hypokalemic and normokalemic periodic paralysis in different members of a single family with novel G515R mutation in SCN4A gene

Novel CACNA1S Mutation Causes Autosomal Dominant Hypokalemic Periodic Paralysis in a South American Family

Hypokalemic Periodic Paralysis Type 2 Due to SCN4A Val1105Met Mutation: A Case Study.

Mutations of SCN4A Gene Cause Different Diseases: 2 Case Reports and Literature Review.

EP.132Central Core Myopathy in Chinese Patients with Nav1.4 P.r675q Mutation

Mutation screening in Chinese hypokalemic periodic paralysis patients.

A Novel Mutation of LRSAM1 in a Chinese Family with Charcot-Marie-Tooth Disease

Hypokalemic periodic paralysis:report of a Chinese pedigree with a novel mutation site in SCN4A gene

Clinical and Genetic Spectrum of a Chinese Cohort with SCN4A Gene Mutations

[Screening of genetic mutations in a Chinese pedigree affected with hypokalemic periodic paralysis]

Clinical, Myopathological Features and Sodium Channel Α-Subunit Encoding Gene Mutation Analysis in 17 Patients with Skeletal Muscle Sodium Channelopathies